TNGX
Companies
NASDAQ
Tango Therapeutics Inc.
Health Care
$4.80
+$1.71 (+55.34%)
Price Chart
Overview
About TNGX
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.
Market Cap
$737.2M
Volume
4.2M
Avg. Volume
4.1M
P/E Ratio
-0.8943662
Dividend Yield
0.00%
Employees
134.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.94
Moderate Correlation
Volatility
High (0.92)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, TNGX shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$737.2M
Volume4.2M
P/E Ratio-0.89
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
February 27, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025